Research Site

Springfield, Oregon 97477

2 studies enrolling now · 8 studies all time

What they study most

Chronic Kidney Disease and Hypertension, Elevated High-sensitivity C-Reactive Protein (hsCRP), Generalized Myasthenia Gravis, Geographic Atrophy, Hypercholesterolemia, Metastatic Castration-resistant Prostate Cancer, Myasthenia Gravis, Prostate Cancer, Relapsed Ovarian Cancer, BRCA Mutation, Platinum Sensitivity

Studies at this site

• A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure — Recruiting now
• A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation — Recruiting now
• A Study of Danicopan in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration — Stopped early
• Study of ALXN2050 in Adult Participants With Generalized Myasthenia Gravis — Stopped early
• Study of Olaparib (Lynparza™) Versus Enzalutamide or Abiraterone Acetate in Men With Metastatic Castration-Resistant Prostate Cancer (PROfound Study) — Completed
• Olaparib Treatment in Relapsed Germline Breast Cancer Susceptibility Gene (BRCA) Mutated Ovarian Cancer Patients Who Have Progressed at Least 6 Months After Last Platinum Treatment and Have Received at Least 2 Prior Platinum Treatments — Completed
• GLobal Assessment of Plaque reGression With a PCSK9 antibOdy as Measured by intraVascular Ultrasound — Completed
• JUPITER - Crestor 20mg Versus Placebo in Prevention of Cardiovascular (CV) Events — Stopped early